Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System.

MLA

Foster, Elizabeth M., et al. “Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System.” Annals of Pharmacotherapy, vol. 58, no. 12, Dec. 2024, pp. 1161–69. EBSCOhost, https://doi.org/10.1177/10600280241243071.

APA

Foster, E. M., Coons, J. C., Puccio, E. A., Sullinger, D., Ibrahim, R., Ibrahim, J., Hickey, G. W., Horn, E., Mosesso, V., & Rivosecchi, R. M. (2024). Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System. Annals of Pharmacotherapy, 58(12), 1161–1169. https://doi.org/10.1177/10600280241243071

Chicago

Foster, Elizabeth M., James C. Coons, Elena A. Puccio, Danine Sullinger, Rachel Ibrahim, Joseph Ibrahim, Gavin W. Hickey, Edward Horn, Vincent Mosesso, and Ryan M. Rivosecchi. 2024. “Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System.” Annals of Pharmacotherapy 58 (12): 1161–69. doi:10.1177/10600280241243071.